Usher Institute

Projects and programmes

Some current projects and programmes; intended to give a flavour of the on-going work at the Usher Institute.

Advanced Care Research Centre (ACRC)

The ACRC is an interdisciplinary research collaboration, combining a complementary programme of research and development to deliver innovation and change to later life care.

All Diseases of Vascular origin: International Collaboration for Evidence (ADVICE)

A group of international researchers and clinicians with expertise in evidence synthesis across a range of vascular disorders, including heart disease, stroke, peripheral arterial disease, vascular dementia and hypertension.

Artificial Intelligence and Multimorbidity: Clustering in Individuals, Space and Clinical Context

AIM-CISC is a research programme that aims to produce a detailed picture of multiple long-term health conditions (MLTCs) in the UK, and use the results of this research to inform future strategies in dealing with this issue.

Co-OPT: consortium for the study of pregnancy treatments

Co-OPT study logo
A new collaborative consortium for the study of pregnancy treatments.

Covid-19 and Tobacco

COVID-19 & Tobacco project logo
Generating evidence to support policy and practice to address tobacco use during and beyond the Covid-19 pandemic.

COVID-19 in Pregnancy in Scotland (COPS)

COPS logo
The COVID-19 in Pregnancy in Scotland (COPS) study aims to find out how COVID-19 infection during pregnancy affects mothers and babies.

DaC-VaP

National Core Studies - Data and Connectivity: COVID-19 Vaccines Pharmacovigilance

The impact of COVID-19 vaccines in pregnancy, children and young people, and vulnerable groups (DaC-VaP-2)

Awarded through a funding call by Health Data Research UK and the Alan Turing Institute, and led by Professor Aziz Sheikh, this project works to use UK-wide data to study the uptake, safety and effectiveness of COVID-19 vaccines.

DASHES

Drugs and Alcohol Service users Help to Exit Smoking

Developing and validating a risk prediction model for Long COVID

Developing and validating a risk prediction model for Long COVID using the EAVE II study in Scotland.

EAVE II

Tracking the COVID-19 pandemic as it happens across Scotland.

ELVIS COVID-19

ELVIS COVID-19 study logo
Could a simple salt water solution help to reduce the early symptoms and progression of COVID-19?

ePAMS+

epams logo
Development and evaluation of a complex ePrescribing-based Antimicrobial Stewardship (ePAMS+) intervention for hospitals.

Global Digital Exemplar (GDE) Programme Evaluation

Digital Exemplars
Formative and summative evaluations of the Global Digital Exemplar (GDE) Programme.

Impact of artificial intelligence on hyperacute stroke diagnostic and treatment pathways – implications for clinicians and the Scottish healthcare system

The project tracks the deployment of stroke AI across Scotland over two years with the aim to establish the effects of AI on practices (e.g., stroke diagnosis and triage), stroke practitioners (e.g., clinicians’ roles and skills), and the Scottish healthcare system (e.g., stroke care pathways).

Innovative Healthcare Delivery Programme (IHDP)

Innovative Healthcare Delivery Programme - IHDP - logo
IHDP seeks to fundamentally change the way data and analytics are used to drive improvement in health outcomes, by fostering new relationships between the NHS, industry, academia, and the third sector.

PRoGRAM-A

PRoGRAM-A team photo including 8 team members at the set up meeting
PReventing Gambling RelAted Harm in Adolescents

RESCEU (REspiratory Syncytial virus Consortium in EUrope)

RESCEU research programme logo Respiratory Syncital Virus Consortium Europe
The RESCEU project aims to develop robust evidence on respiratory syncytial virus (RSV) disease burden and economic impact in Europe and provide infrastructure to perform future pivotal clinical trials for RSV vaccines and therapeutics.

NIHR Global Health Research Unit on Respiratory Health (RESPIRE)

RESPIRE group photo on stage at ASM 2019
Funded by the National Institute for Health Research, RESPIRE is a Global Health Research Unit focusing on respiratory health in Asia.

Rapid Outcomes of COVID therapeutics in Eave II (ROCOVE)

Investigating the uptake, safety, and effectiveness of monoclonal antibody therapy for COVID-19, using EAVE II linked data, working with Public Health Scotland (PHS).

Shaping public health polices to reduce inequalities and harm (SPECTRUM)

SPECTRUM logo
We are a multi-university, multi-agency research consortium focused on the commercial determinants of health and health inequalities funded by the UK Prevention Research Partnership.

Tobacco Control Capacity Programme: building capacity for applied research to reduce tobacco-related harm in low and middle income countries

Tobacco Control Capacity Programme logo
Improving research capacity in Low and Middle Income Countries to conduct high quality studies that will generate evidence on how to reduce morbidity and mortality caused by tobacco use, and to advance key development priorities.

Vaccine Breakthrough Project

Using the EAVE II cohort to investigate the effectiveness of currently administered or future approved vaccines by dose, viral variants and patient clinical and demographic characteristics.

Viral Memories: from HIV to COVID-19 and Beyond

Viral Memories project logo
Viral Memories explores how gay men used their experiences and memories of HIV (and the AIDS crisis) to navigate COVID-19, and how COVID-19 changed how we think of HIV.